Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Marc Fisher, MD, Beth Israel Deaconess Medical Center, Boston, MA, discusses the current state of antithrombotic strategies for secondary prevention after stroke or transient ischemic attack (TIA). Prof. Fisher then discusses how factor XIa inhibitors may change this approach. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.